The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
AM23-ST-15-O - AM23-ST-15-O: Coverage and Reimbursement Policy for Transfusion Medicine and Cellular Therapies: What U.S. Hospitals Need to Know (Enduring)
Transfusion physicians, technologists, managers, and support staff need at least a basic understanding of billing and coding procedures. Those responsible for maintaining appropriate billing and coding must keep up with the constantly changing expectations for coding and billing. This session is designed to provide a comprehensive review of current coding and reimbursement information, including critical updates, and share best practices and case studies from hospitals. AABB staff will also discuss Medicare advocacy and resources to help hospitals ensure they receive appropriate payment.
Learning Objectives:
Describe the current status of Medicare coverage and reimbursement for Transfusion Medicine and Cellular Therapy.
Work through case studies that identify appropriate codes to use to ensure appropriate billing and reimbursement.
Discuss AABB’s advocacy approach for expanded coverage and enhanced reimbursement.
Describe AABB resources that assist with Transfusion Medicine and Cellular Therapy billing and coding needs.
Moderator(s):
Susan
Leppke,
MPH,
Senior Director, Public Policy and Strategic Partnerships,
AABB
Speaker(s):
Justin
Halls,
MD, MPH,
Medical Director of Transfusion Services; Assistant Professor of Pathology,
University of Texas Medical Branch - Galveston
Roxanne
M. Tata,
MT(ASCP) SBB:CQA,
Vice President, Quality System and Regulatory Services,
Vitalant
Disclosures
Justin Halls, MD, MPH:
No financial relationships to disclose
Susan Leppke, MPH:
No financial relationships to disclose
Roxanne Tata, MT(ASCP) SBB:CQA:
No financial relationships to disclose
All relevant financial relationships have been mitigated.
By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.
Credits Available
AM23-ST-15-O: Coverage and Reimbursement Policy for Transfusion Medicine and Cellular Therapies: What U.S. Hospitals Need to Know (Enduring) Evaluation